Pubblicazioni

L’elenco delle pubblicazioni scientifiche con riferimento Fondazione Italiana Fegato è reperibile qui:

SCOPUS – Fondazione Italiana Fegato

Nel 2023, la FIF ha prodotto 26 articoli di cui 14 articoli originali e 11 reviews/editorials ed 1 capitolo di libro con un IF (Impact Factor) totale di 132.70 e un IF medio di 6,31

L’Impact Factor o IF, misura il numero medio di citazioni ricevute, nell’anno di riferimento considerato, dagli articoli pubblicati. E’ pertanto un indicatore della performance e in senso lato della validità degli articoli scientifici, che esprime l’impatto (l’influenza, la popolarità o l’autorevolezza) di una pubblicazione sulla comunità scientifica di riferimento.

Il risultato ottenuto dalla FIF nel 2023 è veramente notevole, e dimostra il livello raggiunto dalla ricerca dei nostri laboratori. Di seguito l’elenco dettagliato dei lavori pubblicati.

Full papers (peer reviewed journals)

  1. Paiano L, Mastronardi M, Campisciano G, Rosso N, Casagranda B, Comar M, de Manzini N, Palmisano S. Liver Bacterial Colonization in Patients with Obesity and Gut Dysbiosis. Obes Surg. 2023 Dec 16. doi: 10.1007/s11695-023-06989-2. DOI: 10.1007/s11695-023-06989-2
  2. Salvoza N, Giraudi PJ, Gazzin S, Bonazza D, de Manzini N, Zanconati F, Palmisano S, Tiribelli C, Rosso N. The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies. J.Translational Med. 2023 DOI: 10.1186/s12967-023-04770-8
  3. Bonfiglio C, Cuccaro F,Campanella A, Rosso N, Tatoli R, Giannelli G and Donghia,R The Protective Role of Oleuropein Aglycone against Pesticide-Induced Toxicity in a Human Keratinocytes Cell Model Nutrients Sept.2023 DOI: 10.3390/nu15214593
  4. Pascut, D; Giraudi, P; Banfi C; Ghilardi, S; Tiribelli, C; Bondesan, A; Caroli D; Minocci A; Grugni, G; Sartorio, A. Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi Syndrome- Front. Endocrinol.Sec. Obesity Oct 2023. https://doi.org/10.3389/fendo.2023.1254778
  5. Cabral LKD, Giraudi PJ, Giannelli G,Dituri F, Negro R, Tiribelli C, Sukowati CHC Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models. Biomedicines 2023, 11(2), 342; https://doi.org/10.3390/biomedicines11020342
  6. Llido J.P., Fioriti E, Pascut D, Giuffrè M, Bottin C, Zanconati F, Tiribelli C, Gazzin S. Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia. Biology 2023, 12, 834. https://doi.org/10.3390/biology12060834.
  7. Mangiapane G, Pascut D, Dalla E, Antoniali G, Degrassi M, Crocè LS, De Sanctis V, Piazza S, Canarutto G, Tiribelli C, Tell G. Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma. J Clin Transl Hepatol. 2023 Nov 28;11(6):1291-1307. doi: 10.14218/JCTH.2022.00179. Epub 2023 Jul 17.PMID: 37719963
  8. Sukowati C, Cabral LKD, Anfuso B, Dituri F, Negro R, Giannelli G, Tiribelli C. PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma. Int J Mol Sci. 2023 Aug 29;24(17):13357. doi: 10.3390/ijms241713357. PMID: 37686163; PMCID: PMC10487900.
  9. Bonfiglio C, Cuccaro F, Campanella A, Rosso N, Tatoli R, Giannelli G, Donghia R. Effect of Intake of Extra Virgin Olive Oil on Mortality in a South Italian Cohort with and without NAFLD. Nutrients. 2023 Oct 29;15(21):4593. doi: 10.3390/nu15214593. PMID: 37960246; PMCID: PMC10649270.
  10. Da Porto A, Donnini D, Vanin F, Romanin A, Antonello M, Toritto P, Varisco E, Brosolo G, Catena C, Sechi LA, Soardo G. Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study. Nutrients. 2023 Apr 14;15(8):1887. doi: 10.3390/nu15081887. PMID: 37111106; PMCID: PMC10144054
  11. Riggio O, Celsa C, Calvaruso V, Merli M, Caraceni P, Montagnese S, Mora V, Milana M, Saracco GM, Raimondo G, Benedetti A, Burra P, Sacco R, Persico M, Schepis F, Villa E, Colecchia A, Fagiuoli S, Pirisi M, Barone M, Azzaroli F, Soardo G, Russello M, Morisco F, Labanca S, Fracanzani AL, Pietrangelo A, Di Maria G, Nardelli S, Ridola L, Gasbarrini A, Cammà C. Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study. Front Med (Lausanne). 2023 May 25;10:1184860. doi: 10.3389/fmed.2023.1184860. PMID: 37305121; PMCID: PMC10248517.

Review articles and editorials 

  1. Hinds, T.D., Jr, Stec, D.E. and Tiribelli, C. (2023), Powering the powerhouse: Heme oxygenase-1 regulates mitochondrial function in non-alcoholic fatty liver disease (NAFLD). Acta Physiol, 237: e13931. https://doi.org/10.1111/apha.13931
  2. Rosso N, Tiribelli C, Editorial: “Talis pater, talis filius” Aliment Pharmacol Ther 2023 Jan; 57(1):171-172. doi: 10.1111/apt.17283
  3. Jayanti S, Dalla Verde C, Tiribelli C, Gazzin S. Inflammation, Dopaminergic Brain and Bilirubin. Int. J. Mol. Sci. 2023, 24, 11478. https://doi.org/10.3390/ ijms241411478
  4. Llido J.P., Jayanti S, Tiribelli C, Gazzin S. Bilirubin and Redox Stress in Age-Related Brain Diseases. Antioxidants 2023, 12, 1525. https://doi.org/10.3390/ antiox12081525
  5. Jayanti S, Vitek L, Dalla Verde C, Llido J.P., Sukowati C, Tiribelli C, Gazzin S, Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases. Biomolecules 2024, 14, 63. https://doi.org/10.3390/biom14010063
  6. El-Khobar KE, Sukowati CHC. Updates on Organoid Model for the Study of Liver Cancer. Technol Cancer Res Treat. 2023 Jan-Dec; 22:15330338231154090. doi: 10.1177/15330338231154090
  7. Agustiningsih, A.; Indalao, I.L.; Pangesti, K.A.; Sukowati, C.H.C.; Ramadhany, R. Molecular Characterization of Influenza A/H3N2 Virus Isolated from Indonesian Hajj and Umrah Pilgrims 2013 to 2014. Life 2023, 13, 1100. https://doi.org/10.3390/life13051100
  8. Sukowati CH, El-Khobar K, Jasirwan COM, Kurniawan J, Gani RA. Stemness markers in hepatocellular carcinoma of Eastern vs. Western population: Etiology matters? Ann Hepatol. 2024 Jan-Feb;29(1):101153. doi: 10.1016/j.aohep.2023.101153. Epub 2023 Sep 19. PMID: 37734662
  9. Aquino IMC, Pascut D. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care. Ann Hepatol. 2024 Mar-Apr;29(2):101176. doi: 10.1016/j.aohep.2023.101176. Epub 2023 Nov 14. PMID: 37972709
  10. Sukowati CHC, Weiz G, Lestari WW, Tiribelli C. Glycosylated-drug Delivery as Targeted Therapy for Hepatocellular Carcinoma: Are We There Yet? Curr Pharm Des. 2023;29(31):2439-2441. doi: 10.2174/0113816128269619231018074301. PMID: 37899637
  11. Vitek L, Hinds, Jr, TD, Stec DE, Tiribelli C, The Physiology of Bilirubin: Health and Disease Equilibrium. Trends Mol Med. 2023 Apr;29(4):315-328. doi: 10.1016/j.molmed.2023.01.007. Epub 2023 Feb 22
  12. Giuffrè M, Moretti R, Tiribelli C. Gut Microbes Meet Machine Learning: The Next Step towards Advancing Our Understanding of the Gut Microbiome in Health and Disease. Int J Mol Sci. 2023 Mar 9;24(6):5229. doi: 10.3390/ijms24065229. PMID: 36982303; PMCID: PMC10049444
  13. Vitek L, Tiribelli C. Gilbert´s syndrome revisited. J Hepatol. 2023 Oct;79(4):1049-1055. doi: 10.1016/j.jhep.2023.06.004. Epub 2023 Jun 28
  14. Shahini E, Pasculli G, Solimando AG, Tiribelli C, Cozzolongo R, Giannelli G. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. Int J Mol Sci. 2023 Feb 21;24(5):4286. doi: 10.3390/ijms24054286. PMID: 36901717; PMCID: PMC10001986

Capitoli di libri
1. Rosso N, Tiribelli C, “Quantitative Sustainability. Interdisciplinary Research for Sustainable Development Goals” Inflammation, Dopaminergic Brain and Bilirubin. – Chapter 4 – Liver and Nutrition. Springer, 2024; 59-66 – DOI: 10.1007/978-3-031-39311-2

Categorie